CITE

    21 USC Sec. 321                                             01/05/2009

EXPCITE

    TITLE 21 - FOOD AND DRUGS
    CHAPTER 9 - FEDERAL FOOD, DRUG, AND COSMETIC ACT
    SUBCHAPTER II - DEFINITIONS

HEAD

    Sec. 321. Definitions; generally

STATUTE

      For the purposes of this chapter -
      (a)(1) The term "State", except as used in the last sentence of
    section 372(a) of this title, means any State or Territory of the
    United States, the District of Columbia, and the Commonwealth of
    Puerto Rico.
      (2) The term "Territory" means any Territory or possession of the
    United States, including the District of Columbia, and excluding
    the Commonwealth of Puerto Rico and the Canal Zone.
      (b) The term "interstate commerce" means (1) commerce between any
    State or Territory and any place outside thereof, and (2) commerce
    within the District of Columbia or within any other Territory not
    organized with a legislative body.
      (c) The term "Department" means Department of Health and Human
    Services.
      (d) The term "Secretary" means the Secretary of Health and Human
    Services.
      (e) The term "person" includes individual, partnership,
    corporation, and association.
      (f) The term "food" means (1) articles used for food or drink for
    man or other animals, (2) chewing gum, and (3) articles used for
    components of any such article.
      (g)(1) The term "drug" means (A) articles recognized in the
    official United States Pharmacopoeia, official Homoeopathic
    Pharmacopoeia of the United States, or official National Formulary,
    or any supplement to any of them; and (B) articles intended for use
    in the diagnosis, cure, mitigation, treatment, or prevention of
    disease in man or other animals; and (C) articles (other than food)
    intended to affect the structure or any function of the body of man
    or other animals; and (D) articles intended for use as a component
    of any article specified in clause (A), (B), or (C). A food or
    dietary supplement for which a claim, subject to sections
    343(r)(1)(B) and 343(r)(3) of this title or sections 343(r)(1)(B)
    and 343(r)(5)(D) of this title, is made in accordance with the
    requirements of section 343(r) of this title is not a drug solely
    because the label or the labeling contains such a claim. A food,
    dietary ingredient, or dietary supplement for which a truthful and
    not misleading statement is made in accordance with section
    343(r)(6) of this title is not a drug under clause (C) solely
    because the label or the labeling contains such a statement.
      (2) The term "counterfeit drug" means a drug which, or the
    container or labeling of which, without authorization, bears the
    trademark, trade name, or other identifying mark, imprint, or
    device, or any likeness thereof, of a drug manufacturer, processor,
    packer, or distributor other than the person or persons who in fact
    manufactured, processed, packed, or distributed such drug and which
    thereby falsely purports or is represented to be the product of, or
    to have been packed or distributed by, such other drug
    manufacturer, processor, packer, or distributor.
      (h) The term "device" (except when used in paragraph (n) of this
    section and in sections 331(i), 343(f), 352(c), and 362(c) of this
    title) means an instrument, apparatus, implement, machine,
    contrivance, implant, in vitro reagent, or other similar or related
    article, including any component, part, or accessory, which is -
        (1) recognized in the official National Formulary, or the
      United States Pharmacopeia, or any supplement to them,
        (2) intended for use in the diagnosis of disease or other
      conditions, or in the cure, mitigation, treatment, or prevention
      of disease, in man or other animals, or
        (3) intended to affect the structure or any function of the
      body of man or other animals, and
    which does not achieve its primary intended purposes through
    chemical action within or on the body of man or other animals and
    which is not dependent upon being metabolized for the achievement
    of its primary intended purposes.
      (i) The term "cosmetic" means (1) articles intended to be rubbed,
    poured, sprinkled, or sprayed on, introduced into, or otherwise
    applied to the human body or any part thereof for cleansing,
    beautifying, promoting attractiveness, or altering the appearance,
    and (2) articles intended for use as a component of any such
    articles; except that such term shall not include soap.
      (j) The term "official compendium" means the official United
    States Pharmacopoeia, official Homoeopathic Pharmacopoeia of the
    United States, official National Formulary, or any supplement to
    any of them.
      (k) The term "label" means a display of written, printed, or
    graphic matter upon the immediate container of any article; and a
    requirement made by or under authority of this chapter that any
    word, statement, or other information appear on the label shall not
    be considered to be complied with unless such word, statement, or
    other information also appears on the outside container or wrapper,
    if any there be, of the retail package of such article, or is
    easily legible through the outside container or wrapper.
      (l) The term "immediate container" does not include package
    liners.
      (m) The term "labeling" means all labels and other written,
    printed, or graphic matter (1) upon any article or any of its
    containers or wrappers, or (2) accompanying such article.
      (n) If an article is alleged to be misbranded because the
    labeling or advertising is misleading, then in determining whether
    the labeling or advertising is misleading there shall be taken into
    account (among other things) not only representations made or
    suggested by statement, word, design, device, or any combination
    thereof, but also the extent to which the labeling or advertising
    fails to reveal facts material in the light of such representations
    or material with respect to consequences which may result from the
    use of the article to which the labeling or advertising relates
    under the conditions of use prescribed in the labeling or
    advertising thereof or under such conditions of use as are
    customary or usual.
      (o) The representation of a drug, in its labeling, as an
    antiseptic shall be considered to be a representation that it is a
    germicide, except in the case of a drug purporting to be, or
    represented as, an antiseptic for inhibitory use as a wet dressing,
    ointment, dusting powder, or such other use as involves prolonged
    contact with the body.
      (p) The term "new drug" means -
        (1) Any drug (except a new animal drug or an animal feed
      bearing or containing a new animal drug) the composition of which
      is such that such drug is not generally recognized, among experts
      qualified by scientific training and experience to evaluate the
      safety and effectiveness of drugs, as safe and effective for use
      under the conditions prescribed, recommended, or suggested in the
      labeling thereof, except that such a drug not so recognized shall
      not be deemed to be a "new drug" if at any time prior to June 25,
      1938, it was subject to the Food and Drugs Act of June 30, 1906,
      as amended, and if at such time its labeling contained the same
      representations concerning the conditions of its use; or
        (2) Any drug (except a new animal drug or an animal feed
      bearing or containing a new animal drug) the composition of which
      is such that such drug, as a result of investigations to
      determine its safety and effectiveness for use under such
      conditions, has become so recognized, but which has not,
      otherwise than in such investigations, been used to a material
      extent or for a material time under such conditions.
      (q)(1)(A) Except as provided in clause (B), the term "pesticide
    chemical" means any substance that is a pesticide within the
    meaning of the Federal Insecticide, Fungicide, and Rodenticide Act
    [7 U.S.C. 136 et seq.], including all active and inert ingredients
    of such pesticide. Notwithstanding any other provision of law, the
    term "pesticide" within such meaning includes ethylene oxide and
    propylene oxide when such substances are applied on food.
      (B) In the case of the use, with respect to food, of a substance
    described in clause (A) to prevent, destroy, repel, or mitigate
    microorganisms (including bacteria, viruses, fungi, protozoa,
    algae, and slime), the following applies for purposes of clause
    (A):
        (i) The definition in such clause for the term "pesticide
      chemical" does not include the substance if the substance is
      applied for such use on food, or the substance is included for
      such use in water that comes into contact with the food, in the
      preparing, packing, or holding of the food for commercial
      purposes. The substance is not excluded under this subclause from
      such definition if the substance is ethylene oxide or propylene
      oxide, and is applied for such use on food. The substance is not
      so excluded if the substance is applied for such use on a raw
      agricultural commodity, or the substance is included for such use
      in water that comes into contact with the commodity, as follows:
          (I) The substance is applied in the field.
          (II) The substance is applied at a treatment facility where
        raw agricultural commodities are the only food treated, and the
        treatment is in a manner that does not change the status of the
        food as a raw agricultural commodity (including treatment
        through washing, waxing, fumigating, and packing such
        commodities in such manner).
          (III) The substance is applied during the transportation of
        such commodity between the field and such a treatment facility.
        (ii) The definition in such clause for the term "pesticide
      chemical" does not include the substance if the substance is a
      food contact substance as defined in section 348(h)(6) of this
      title, and any of the following circumstances exist: The
      substance is included for such use in an object that has a food
      contact surface but is not intended to have an ongoing effect on
      any portion of the object; the substance is included for such use
      in an object that has a food contact surface and is intended to
      have an ongoing effect on a portion of the object but not on the
      food contact surface; or the substance is included for such use
      in or is applied for such use on food packaging (without regard
      to whether the substance is intended to have an ongoing effect on
      any portion of the packaging). The food contact substance is not
      excluded under this subclause from such definition if any of the
      following circumstances exist: The substance is applied for such
      use on a semipermanent or permanent food contact surface (other
      than being applied on food packaging); or the substance is
      included for such use in an object that has a semipermanent or
      permanent food contact surface (other than being included in food
      packaging) and the substance is intended to have an ongoing
      effect on the food contact surface.
    With respect to the definition of the term "pesticide" that is
    applicable to the Federal Insecticide, Fungicide, and Rodenticide
    Act [7 U.S.C. 136 et seq.], this clause does not exclude any
    substance from such definition.
      (2) The term "pesticide chemical residue" means a residue in or
    on raw agricultural commodity or processed food of -
        (A) a pesticide chemical; or
        (B) any other added substance that is present on or in the
      commodity or food primarily as a result of the metabolism or
      other degradation of a pesticide chemical.
      (3) Notwithstanding subparagraphs (1) and (2), the Administrator
    may by regulation except a substance from the definition of
    "pesticide chemical" or "pesticide chemical residue" if -
        (A) its occurrence as a residue on or in a raw agricultural
      commodity or processed food is attributable primarily to natural
      causes or to human activities not involving the use of any
      substances for a pesticidal purpose in the production, storage,
      processing, or transportation of any raw agricultural commodity
      or processed food; and
        (B) the Administrator, after consultation with the Secretary,
      determines that the substance more appropriately should be
      regulated under one or more provisions of this chapter other than
      sections 342(a)(2)(B) and 346a of this title.
      (r) The term "raw agricultural commodity" means any food in its
    raw or natural state, including all fruits that are washed,
    colored, or otherwise treated in their unpeeled natural form prior
    to marketing.
      (s) The term "food additive" means any substance the intended use
    of which results or may reasonably be expected to result, directly
    or indirectly, in its becoming a component or otherwise affecting
    the characteristics of any food (including any substance intended
    for use in producing, manufacturing, packing, processing,
    preparing, treating, packaging, transporting, or holding food; and
    including any source of radiation intended for any such use), if
    such substance is not generally recognized, among experts qualified
    by scientific training and experience to evaluate its safety, as
    having been adequately shown through scientific procedures (or, in
    the case of a substance used in food prior to January 1, 1958,
    through either scientific procedures or experience based on common
    use in food) to be safe under the conditions of its intended use;
    except that such term does not include -
        (1) a pesticide chemical residue in or on a raw agricultural
      commodity or processed food; or
        (2) a pesticide chemical; or
        (3) a color additive; or
        (4) any substance used in accordance with a sanction or
      approval granted prior to September 6, 1958, pursuant to this
      chapter, the Poultry Products Inspection Act [21 U.S.C. 451 et
      seq.] or the Meat Inspection Act of March 4, 1907, as amended and
      extended [21 U.S.C. 601 et seq.];
        (5) a new animal drug; or
        (6) an ingredient described in paragraph (ff) in, or intended
      for use in, a dietary supplement.
      (t)(1) The term "color additive" means a material which -
        (A) is a dye, pigment, or other substance made by a process of
      synthesis or similar artifice, or extracted, isolated, or
      otherwise derived, with or without intermediate or final change
      of identity, from a vegetable, animal, mineral, or other source,
      and
        (B) when added or applied to a food, drug, or cosmetic, or to
      the human body or any part thereof, is capable (alone or through
      reaction with other substance) of imparting color thereto;
    except that such term does not include any material which the
    Secretary, by regulation, determines is used (or intended to be
    used) solely for a purpose or purposes other than coloring.
      (2) The term "color" includes black, white, and intermediate
    grays.
      (3) Nothing in subparagraph (1) of this paragraph shall be
    construed to apply to any pesticide chemical, soil or plant
    nutrient, or other agricultural chemical solely because of its
    effect in aiding, retarding, or otherwise affecting, directly or
    indirectly, the growth or other natural physiological processes of
    produce of the soil and thereby affecting its color, whether before
    or after harvest.
      (u) The term "safe" as used in paragraph (s) of this section and
    in sections 348, 360b, 360ccc, and 379e of this title, has
    reference to the health of man or animal.
      (v) The term "new animal drug" means any drug intended for use
    for animals other than man, including any drug intended for use in
    animal feed but not including such animal feed, -
        (1) the composition of which is such that such drug is not
      generally recognized, among experts qualified by scientific
      training and experience to evaluate the safety and effectiveness
      of animal drugs, as safe and effective for use under the
      conditions prescribed, recommended, or suggested in the labeling
      thereof; except that such a drug not so recognized shall not be
      deemed to be a "new animal drug" if at any time prior to June 25,
      1938, it was subject to the Food and Drug Act of June 30, 1906,
      as amended, and if at such time its labeling contained the same
      representations concerning the conditions of its use; or
        (2) the composition of which is such that such drug, as a
      result of investigations to determine its safety and
      effectiveness for use under such conditions, has become so
      recognized but which has not, otherwise than in such
      investigations, been used to a material extent or for a material
      time under such conditions.
    Provided that any drug intended for minor use or use in a minor
    species that is not the subject of a final regulation published by
    the Secretary through notice and comment rulemaking finding that
    the criteria of paragraphs (1) and (2) have not been met (or that
    the exception to the criterion in paragraph (1) has been met) is a
    new animal drug.
      (w) The term "animal feed", as used in paragraph (w) (!1) of this
    section, in section 360b of this title, and in provisions of this
    chapter referring to such paragraph or section, means an article
    which is intended for use for food for animals other than man and
    which is intended for use as a substantial source of nutrients in
    the diet of the animal, and is not limited to a mixture intended to
    be the sole ration of the animal.
      (x) The term "informal hearing" means a hearing which is not
    subject to section 554, 556, or 557 of title 5 and which provides
    for the following:
        (1) The presiding officer in the hearing shall be designated by
      the Secretary from officers and employees of the Department who
      have not participated in any action of the Secretary which is the
      subject of the hearing and who are not directly responsible to an
      officer or employee of the Department who has participated in any
      such action.
        (2) Each party to the hearing shall have the right at all times
      to be advised and accompanied by an attorney.
        (3) Before the hearing, each party to the hearing shall be
      given reasonable notice of the matters to be considered at the
      hearing, including a comprehensive statement of the basis for the
      action taken or proposed by the Secretary which is the subject of
      the hearing and a general summary of the information which will
      be presented by the Secretary at the hearing in support of such
      action.
        (4) At the hearing the parties to the hearing shall have the
      right to hear a full and complete statement of the action of the
      Secretary which is the subject of the hearing together with the
      information and reasons supporting such action, to conduct
      reasonable questioning, and to present any oral or written
      information relevant to such action.
        (5) The presiding officer in such hearing shall prepare a
      written report of the hearing to which shall be attached all
      written material presented at the hearing. The participants in
      the hearing shall be given the opportunity to review and correct
      or supplement the presiding officer's report of the hearing.
        (6) The Secretary may require the hearing to be transcribed. A
      party to the hearing shall have the right to have the hearing
      transcribed at his expense. Any transcription of a hearing shall
      be included in the presiding officer's report of the hearing.
      (y) The term "saccharin" includes calcium saccharin, sodium
    saccharin, and ammonium saccharin.
      (z) The term "infant formula" means a food which purports to be
    or is represented for special dietary use solely as a food for
    infants by reason of its simulation of human milk or its
    suitability as a complete or partial substitute for human milk.
      (aa) The term "abbreviated drug application" means an application
    submitted under section 355(j) of this title for the approval of a
    drug that relies on the approved application of another drug with
    the same active ingredient to establish safety and efficacy, and -
        (1) in the case of section 335a of this title, includes a
      supplement to such an application for a different or additional
      use of the drug but does not include a supplement to such an
      application for other than a different or additional use of the
      drug, and
        (2) in the case of sections 335b and 335c of this title,
      includes any supplement to such an application.
      (bb) The term "knowingly" or "knew" means that a person, with
    respect to information -
        (1) has actual knowledge of the information, or
        (2) acts in deliberate ignorance or reckless disregard of the
      truth or falsity of the information.
      (cc) For purposes of section 335a of this title, the term "high
    managerial agent" -
        (1) means -
          (A) an officer or director of a corporation or an
        association,
          (B) a partner of a partnership, or
          (C) any employee or other agent of a corporation,
        association, or partnership,
      having duties such that the conduct of such officer, director,
      partner, employee, or agent may fairly be assumed to represent
      the policy of the corporation, association, or partnership, and
        (2) includes persons having management responsibility for -
          (A) submissions to the Food and Drug Administration regarding
        the development or approval of any drug product,
          (B) production, quality assurance, or quality control of any
        drug product, or
          (C) research and development of any drug product.
      (dd) For purposes of sections 335a and 335b of this title, the
    term "drug product" means a drug subject to regulation under
    section 355, 360b, or 382 of this title or under section 262 of
    title 42.
      (ee) The term "Commissioner" means the Commissioner of Food and
    Drugs.
      (ff) The term "dietary supplement" -
        (1) means a product (other than tobacco) intended to supplement
      the diet that bears or contains one or more of the following
      dietary ingredients:
          (A) a vitamin;
          (B) a mineral;
          (C) an herb or other botanical;
          (D) an amino acid;
          (E) a dietary substance for use by man to supplement the diet
        by increasing the total dietary intake; or
          (F) a concentrate, metabolite, constituent, extract, or
        combination of any ingredient described in clause (A), (B),
        (C), (D), or (E);
        (2) means a product that -
          (A)(i) is intended for ingestion in a form described in
        section 350(c)(1)(B)(i) of this title; or
          (ii) complies with section 350(c)(1)(B)(ii) of this title;
          (B) is not represented for use as a conventional food or as a
        sole item of a meal or the diet; and
          (C) is labeled as a dietary supplement; and
        (3) does -
          (A) include an article that is approved as a new drug under
        section 355 of this title or licensed as a biologic under
        section 262 of title 42 and was, prior to such approval,
        certification, or license, marketed as a dietary supplement or
        as a food unless the Secretary has issued a regulation, after
        notice and comment, finding that the article, when used as or
        in a dietary supplement under the conditions of use and dosages
        set forth in the labeling for such dietary supplement, is
        unlawful under section 342(f) of this title; and
          (B) not include -
            (i) an article that is approved as a new drug under section
          355 of this title, certified as an antibiotic under section
          357 of this title, or licensed as a biologic under section
          262 of title 42, or
            (ii) an article authorized for investigation as a new drug,
          antibiotic, or biological for which substantial clinical
          investigations have been instituted and for which the
          existence of such investigations has been made public,
      which was not before such approval, certification, licensing, or
      authorization marketed as a dietary supplement or as a food
      unless the Secretary, in the Secretary's discretion, has issued a
      regulation, after notice and comment, finding that the article
      would be lawful under this chapter.
    Except for purposes of paragraph (g) and section 350f of this
    title, a dietary supplement shall be deemed to be a food within the
    meaning of this chapter.
      (gg) The term "processed food" means any food other than a raw
    agricultural commodity and includes any raw agricultural commodity
    that has been subject to processing, such as canning, cooking,
    freezing, dehydration, or milling.
      (hh) The term "Administrator" means the Administrator of the
    United States Environmental Protection Agency.
      (ii) The term "compounded positron emission tomography drug" -
        (1) means a drug that -
          (A) exhibits spontaneous disintegration of unstable nuclei by
        the emission of positrons and is used for the purpose of
        providing dual photon positron emission tomographic diagnostic
        images; and
          (B) has been compounded by or on the order of a practitioner
        who is licensed by a State to compound or order compounding for
        a drug described in subparagraph (A), and is compounded in
        accordance with that State's law, for a patient or for
        research, teaching, or quality control; and
        (2) includes any nonradioactive reagent, reagent kit,
      ingredient, nuclide generator, accelerator, target material,
      electronic synthesizer, or other apparatus or computer program to
      be used in the preparation of such a drug.
      (jj) The term "antibiotic drug" means any drug (except drugs for
    use in animals other than humans) composed wholly or partly of any
    kind of penicillin, streptomycin, chlortetracycline,
    chloramphenicol, bacitracin, or any other drug intended for human
    use containing any quantity of any chemical substance which is
    produced by a micro-organism and which has the capacity to inhibit
    or destroy micro-organisms in dilute solution (including a
    chemically synthesized equivalent of any such substance) or any
    derivative thereof.
      (kk) Priority supplement. - The term "priority supplement" means
    a drug application referred to in section 101(4) of the Food and
    Drug Administration Modernization Act of 1997 (111 Stat. 2298).
      (ll)(1) The term "single-use device" means a device that is
    intended for one use, or on a single patient during a single
    procedure.
      (2)(A) The term "reprocessed", with respect to a single-use
    device, means an original device that has previously been used on a
    patient and has been subjected to additional processing and
    manufacturing for the purpose of an additional single use on a
    patient. The subsequent processing and manufacture of a reprocessed
    single-use device shall result in a device that is reprocessed
    within the meaning of this definition.
      (B) A single-use device that meets the definition under clause
    (A) shall be considered a reprocessed device without regard to any
    description of the device used by the manufacturer of the device or
    other persons, including a description that uses the term
    "recycled" rather than the term "reprocessed".
      (3) The term "original device" means a new, unused single-use
    device.
      (mm)(1) The term "critical reprocessed single-use device" means a
    reprocessed single-use device that is intended to contact normally
    sterile tissue or body spaces during use.
      (2) The term "semi-critical reprocessed single-use device" means
    a reprocessed single-use device that is intended to contact intact
    mucous membranes and not penetrate normally sterile areas of the
    body.
      (nn) The term "major species" means cattle, horses, swine,
    chickens, turkeys, dogs, and cats, except that the Secretary may
    add species to this definition by regulation.
      (oo) The term "minor species" means animals other than humans
    that are not major species.
      (pp) The term "minor use" means the intended use of a drug in a
    major species for an indication that occurs infrequently and in
    only a small number of animals or in limited geographical areas and
    in only a small number of animals annually.
      (qq) The term "major food allergen" means any of the following:
        (1) Milk, egg, fish (e.g., bass, flounder, or cod), Crustacean
      shellfish (e.g., crab, lobster, or shrimp), tree nuts (e.g.,
      almonds, pecans, or walnuts), wheat, peanuts, and soybeans.
        (2) A food ingredient that contains protein derived from a food
      specified in paragraph (1), except the following:
          (A) Any highly refined oil derived from a food specified in
        paragraph (1) and any ingredient derived from such highly
        refined oil.
          (B) A food ingredient that is exempt under paragraph (6) or
        (7) of section 343(w) of this title.

SOURCE

    (June 25, 1938, ch. 675, Sec. 201, 52 Stat. 1040; July 22, 1954,
    ch. 559, Sec. 1, 68 Stat. 511; Pub. L. 85-929, Sec. 2, Sept. 6,
    1958, 72 Stat. 1784; Pub. L. 86-618, title I, Sec. 101, July 12,
    1960, 74 Stat. 397; Pub. L. 87-781, title I, Sec. 102(a), title
    III, Sec. 307(a), Oct. 10, 1962, 76 Stat. 781, 796; Pub. L. 89-74,
    Secs. 3(a), 9(b), July 15, 1965, 79 Stat. 227, 234; Pub. L. 90-399,
    Sec. 102, July 13, 1968, 82 Stat. 351; Pub. L. 90-639, Secs. 1,
    4(a), Oct. 24, 1968, 82 Stat. 1361, 1362; Pub. L. 91-513, title II,
    Sec. 701(a), (g), Oct. 27, 1970, 84 Stat. 1281, 1282; Pub. L. 92-
    516, Sec. 3(3), Oct. 21, 1972, 86 Stat. 998; Pub. L. 94-278, title
    V, Sec. 502(a)(2)(A), Apr. 22, 1976, 90 Stat. 411; Pub. L. 94-295,
    Sec. 3(a)(1)(A), (2), May 28, 1976, 90 Stat. 575; Pub. L. 95-203,
    Sec. 4(b)(3), Nov. 23, 1977, 91 Stat. 1453; Pub. L. 96-359, Sec. 3,
    Sept. 26, 1980, 94 Stat. 1193; Pub. L. 100-670, title I, Sec.
    107(a)(1), Nov. 16, 1988, 102 Stat. 3984; Pub. L. 101-535, Sec.
    5(b), Nov. 8, 1990, 104 Stat. 2362; Pub. L. 101-629, Sec. 16(b),
    Nov. 28, 1990, 104 Stat. 4526; Pub. L. 102-282, Sec. 6, May 13,
    1992, 106 Stat. 161; Pub. L. 102-300, Sec. 6(a), (b), June 16,
    1992, 106 Stat. 240; Pub. L. 102-571, title I, Sec. 107(1), Oct.
    29, 1992, 106 Stat. 4499; Pub. L. 103-80, Secs. 3(b), (dd)(1),
    4(b), Aug. 13, 1993, 107 Stat. 775, 779; Pub. L. 103-417, Secs.
    3(a), (b), 10(a), Oct. 25, 1994, 108 Stat. 4327, 4332; Pub. L. 104-
    170, title IV, Sec. 402, Aug. 3, 1996, 110 Stat. 1513; Pub. L. 105-
    115, title I, Secs. 121(a), 125(b)(2)(A), (e), Nov. 21, 1997, 111
    Stat. 2320, 2325, 2327; Pub. L. 105-324, Sec. 2(a), (c), Oct. 30,
    1998, 112 Stat. 3035, 3037; Pub. L. 107-109, Sec. 5(b)(1), Jan. 4,
    2002, 115 Stat. 1413; Pub. L. 107-250, title III, Sec. 302(d), Oct.
    26, 2002, 116 Stat. 1619; Pub. L. 108-282, title I, Sec. 102(b)(1),
    (5)(A), (B), title II, Sec. 203(c)(1), Aug. 2, 2004, 118 Stat. 891,
    902, 908; Pub. L. 110-85, title X, Sec. 1005(c), Sept. 27, 2007,
    121 Stat. 968.)

REFERENCES IN TEXT

      The Food and Drugs Act of June 30, 1906, as amended, referred to
    in par. (p)(1), and the Food and Drug Act of June 30, 1906, as
    amended, referred to in par. (v)(1), is act June 30, 1906, ch.
    3915, 34 Stat. 768, as amended, which was classified to subchapter
    I (Sec. 1 et seq.) of chapter 1 of this title, was repealed (except
    for section 14a which was transferred to section 372a of this
    title) by act June 25, 1938, ch. 675, Sec. 902(a), 52 Stat. 1059,
    and is covered by this chapter.
      The Federal Insecticide, Fungicide, and Rodenticide Act, referred
    to in par. (q)(1), is act June 25, 1947, ch. 125, as amended
    generally by Pub. L. 92-516, Oct. 21, 1972, 86 Stat. 973, which is
    classified generally to subchapter II (Sec. 136 et seq.) of chapter
    6 of Title 7, Agriculture. For complete classification of this Act
    to the Code, see Short Title note set out under section 136 of
    Title 7 and Tables.
      The Poultry Products Inspection Act, referred to in par. (s)(4),
    is Pub. L. 85-172, Aug. 28, 1957, 71 Stat. 441, as amended, which
    is classified generally to chapter 10 (Sec. 451 et seq.) of this
    title. For complete classification of this Act to the Code, see
    Short Title note set out under section 451 of this title and
    Tables.
      The Meat Inspection Act of March 4, 1907, as amended and
    extended, referred to in par. (s)(4), is act Mar. 4, 1907, ch.
    2907, titles I to IV, as added Dec. 15, 1967, Pub. L. 90-201, 81
    Stat. 584, which are classified generally to subchapters I to IV
    (Sec. 601 et seq.) of chapter 12 of this title. For complete
    classification of this Act to the Code, see Short Title note set
    out under section 601 of this title and Tables.
      Section 101(4) of the Food and Drug Administration Modernization
    Act of 1997, referred to in par. (kk), is section 101(4) of Pub. L.
    105-115, which is set out as a note under section 379g of this
    title.

AMENDMENTS

      2007 - Par. (ff). Pub. L. 110-85 substituted "paragraph (g) and
    section 350f of this title" for "paragraph (g)" in concluding
    provisions.
      2004-Par. (u). Pub. L. 108-282, Sec. 102(b)(5)(A), substituted
    "360b, 360ccc" for "360b".
      Par. (v). Pub. L. 108-282, Sec. 102(b)(5)(B), inserted concluding
    provisions.
      Pars. (nn) to (pp). Pub. L. 108-282, Sec. 102(b)(1), added pars.
    (nn) to (pp).
      Par. (qq). Pub. L. 108-282, Sec. 203(c)(1), added par. (qq).
      2002 - Par. (kk). Pub. L. 107-109 added par. (kk).
      Pars. (ll), (mm). Pub. L. 107-250 added pars. (ll) and (mm).
      1998 - Par. (q)(1). Pub. L. 105-324, Sec. 2(a), added subpar. (1)
    and struck out former subpar. (1) which read as follows: "The term
    'pesticide chemical' means any substance that is a pesticide within
    the meaning of the Federal Insecticide, Fungicide, and Rodenticide
    Act, including all active and inert ingredients of such pesticide."
      Par. (q)(3). Pub. L. 105-324, Sec. 2(c), substituted
    "subparagraphs (1) and (2)" for "paragraphs (1) and (2)" in
    introductory provisions.
      1997 - Par. (aa). Pub. L. 105-115, Sec. 125(b)(2)(A), struck out
    "or 357" after "section 355(j)".
      Par. (dd). Pub. L. 105-115, Sec. 125(b)(2)(A), struck out "357,"
    after "section 355,".
      Par. (ff)(3)(A). Pub. L. 105-115, Sec. 125(b)(2)(A), struck out
    ", certified as an antibiotic under section 357 of this title,"
    before "or licensed as a biologic".
      Par. (ii). Pub. L. 105-115, Sec. 121(a), added par. (ii).
      Par. (jj). Pub. L. 105-115, Sec. 125(e), added par. (jj).
      1996 - Par. (q). Pub. L. 104-170, Sec. 402(a), amended par. (q)
    generally. Prior to amendment, par. (q) read as follows: "The term
    'pesticide chemical' means any substance which, alone, in chemical
    combination or in formulation with one or more other substances, is
    'a pesticide' within the meaning of the Federal Insecticide,
    Fungicide, and Rodenticide Act as now in force or as hereafter
    amended, and which is used in the production, storage, or
    transportation of raw agricultural commodities."
      Par. (s)(1), (2). Pub. L. 104-170, Sec. 402(b), amended subpars.
    (1) and (2) generally. Prior to amendment, subpars. (1) and (2)
    read as follows:
      "(1) a pesticide chemical in or on a raw agricultural commodity;
    or
      "(2) a pesticide chemical to the extent that it is intended for
    use or is used in the production, storage, or transportation of any
    raw agricultural commodity; or".
      Pars. (gg), (hh). Pub. L. 104-170, Sec. 402(c), added pars. (gg)
    and (hh).
      1994 - Par. (g)(1). Pub. L. 103-417, Sec. 10(a), amended last
    sentence generally. Prior to amendment, last sentence read as
    follows: "A food for which a claim, subject to sections
    343(r)(1)(B) and 343(r)(3) of this title or sections 343(r)(1)(B)
    and 343(r)(5)(D) of this title, is made in accordance with the
    requirements of section 343(r) of this title is not a drug under
    clause (B) solely because the label or labeling contains such a
    claim."
      Par. (s)(6). Pub. L. 103-417, Sec. 3(b), added subpar. (6).
      Par. (ff). Pub. L. 103-417, Sec. 3(a), added par. (ff).
      1993 - Pars. (c), (d). Pub. L. 103-80, Sec. 3(dd)(1), substituted
    "Health and Human Services" for "Agriculture".
      Par. (h). Pub. L. 103-80, Sec. 4(b), amended directory language
    of Pub. L. 102-300, Sec. 6(a)(1). See 1992 amendment note below.
      Pars. (v) to (ff). Pub. L. 103-80, Sec. 3(b), redesignated pars.
    (w) to (ff) as (v) to (ee), respectively.
      1992 - Pars. (c), (d). Pub. L. 102-300, Sec. 6(b)(1), which
    directed the substitution of "Health and Human Services" for
    "Health, Education, and Welfare", could not be executed because
    such words did not appear in the original statutory text. See 1993
    Amendment note above and Transfer of Functions notes below.
      Par. (h). Pub. L. 102-300, Sec. 6(a)(1), as amended by Pub. L.
    103-80, Sec. 4(b), substituted "its primary" for "any of its
    principal" in two places in concluding provisions.
      Par. (u). Pub. L. 102-571 substituted "379e" for "376".
      Par. (y)(1). Pub. L. 102-300, Sec. 6(b)(2), struck out "of
    Health, Education, and Welfare" after "employees of the
    Department".
      Pars. (bb) to (ee). Pub. L. 102-282 added pars. (bb) to (ee).
      Par. (ff). Pub. L. 102-300, Sec. 6(a)(2), added par. (ff).
      1990 - Par. (g)(1). Pub. L. 101-629, Sec. 16(b)(1), struck out ";
    but does not include devices or their components, parts, or
    accessories" after "clause (A), (B), or (C)".
      Pub. L. 101-535 inserted at end "A food for which a claim,
    subject to sections 343(r)(1)(B) and 343(r)(3) of this title or
    sections 343(r)(1)(B) and 343(r)(5)(D) of this title, is made in
    accordance with the requirements of section 343(r) of this title is
    not a drug under clause (B) solely because the label or labeling
    contains such a claim."
      Par. (h)(3). Pub. L. 101-629, Sec. 16(b)(2), which directed the
    amendment of subpar. (3) by substituting "its primary" for "any of
    its principal", could not be executed because "any of its
    principal" did not appear in subpar. (3).
      1988 - Par. (w)(3). Pub. L. 100-670 struck out subpar. (3) which
    read as follows: "which drug is composed wholly or partly of any
    kind of penicillin, streptomycin, chlortetracycline,
    chloramphenicol, or bacitracin, or any derivative thereof, except
    when there is in effect a published order of the Secretary
    declaring such drug not to be a new animal drug on the grounds that
    (A) the requirement of certification of batches of such drug, as
    provided for in section 360b(n) of this title, is not necessary to
    insure that the objectives specified in paragraph (3) thereof are
    achieved and (B) that neither subparagraph (1) nor (2) of this
    paragraph (w) applies to such drug."
      1980 - Par. (aa). Pub. L. 96-359 added par. (aa).
      1977 - Par. (z). Pub. L. 95-203 added par. (z).
      1976 - Par. (h). Pub. L. 94-295, Sec. 3(a)(1)(A), expanded
    definition of "device" to include implements, machines, implants,
    in vitro reagents, and other similar or related articles, added
    recognition in the National Formulary or the United States
    Pharmacopeia, or any supplement to the Formulary or Pharmacopeia,
    to the enumeration of conditions under which a device may qualify
    for inclusion under this chapter, and inserted requirements that a
    device be one which does not achieve any of its principal intended
    purposes through chemical action within or on the body of man or
    other animals and which is not dependent upon being metabolized for
    the achievement of any of its principal intended purposes.
      Par. (n). Pub. L. 94-278 inserted "or advertising" after
    "labeling" wherever appearing.
      Par. (y). Pub. L. 94-295, Sec. 3(a)(2), added par. (y).
      1972 - Par. (q). Pub. L. 92-516 substituted reference to
    pesticide for reference to economic poison.
      1970 - Par. (a)(2). Pub. L. 91-513, Sec. 701(g), struck out
    reference to sections 321, 331(i), 331(p), 331(q), 332, 333, 334,
    337, 360, 360a, 372, 373, 374, and 375 of this title as they apply
    to depressant or stimulant drugs.
      Par. (v). Pub. L. 91-513, Sec. 701(a), struck out par. (v) which
    defined "depressant or stimulant drug".
      1968 - Par. (a)(2). Pub. L. 90-639, Sec. 4(a), extended
    provisions to cover depressant and stimulant drugs, the containers
    thereof, and equipment used in manufacturing, compounding, or
    processing such drugs, to the Canal Zone.
      Par. (p). Pub. L. 90-399, Sec. 102(a), (b), inserted "(except a
    new animal drug or an animal feed bearing or containing a new
    animal drug)" after "Any drug" in subpars. (1) and (2),
    respectively.
      Par. (s)(5). Pub. L. 90-399, Sec. 102(c), added subpar. (5).
      Par. (u). Pub. L. 90-399, Sec. 102(d), inserted reference to
    section 360b of this title.
      Par. (v)(3). Pub. L. 90-639, Sec. 1, inserted reference to
    lysergic acid diethylamide.
      Pars. (w), (x). Pub. L. 90-399, Sec. 102(e), added pars. (w) and
    (x).
      1965 - Par. (g). Pub. L. 89-74, Sec. 9(b), designated existing
    provisions as subpar. (1), redesignated cls. (1) to (4) thereof as
    (A) to (D), substituted "(A), (B), or (C)" for "(1), (2), or (3)"
    and added subpar. (2).
      Par. (v). Pub. L. 89-74, Sec. 3(a), added par. (v).
      1962 - Par. (a). Pub. L. 87-781, Sec. 307(a), designated existing
    provisions as subpar. (2), inserted "Commonwealth of Puerto Rico
    and the", and added subpar. (1).
      Par. (p)(1). Pub. L. 87-781, Sec. 102(a)(1), inserted "and
    effectiveness" after "to evaluate the safety", and "and effective"
    after "as safe".
      Par. (p)(2). Pub. L. 87-781, Sec. 102(a)(2), inserted "and
    effectiveness" after "safety".
      1960 - Par. (s). Pub. L. 86-618, Sec. 101(a), excluded color
    additives from definition of "food additive".
      Par. (t). Pub. L. 86-618, Sec. 101(c), added par. (t). Former
    par. (t) redesignated (u).
      Par. (u). Pub. L. 86-618, Sec. 101(b), redesignated par. (t) as
    (u) and inserted reference to section 376 of this title.
      1958 - Pars. (s), (t). Pub. L. 85-929 added pars. (s) and (t).
      1954 - Pars. (q), (r). Act July 22, 1954, added pars. (q) and
    (r).
                     EFFECTIVE DATE OF 2004 AMENDMENT
      Pub. L. 108-282, title II, Sec. 203(d), Aug. 2, 2004, 118 Stat.
    908, provided that: "The amendments made by this section [amending
    this section and sections 343 and 343-1 of this title] shall apply
    to any food that is labeled on or after January 1, 2006."
                     EFFECTIVE DATE OF 1997 AMENDMENT
      Section 501 of Pub. L. 105-115 provided that: "Except as
    otherwise provided in this Act [see Short Title of 1997 Amendment
    note set out under section 301 of this title], this Act and the
    amendments made by this Act, other than the provisions of and the
    amendments made by sections 111, 121, 125, and 307 [enacting
    section 355a of this title, amending this section and sections 331,
    335a, 351, 352, 360, 360j, 360aa to 360cc, 360ee, 374, 379g, 381,
    and 382 of this title, section 45C of Title 26, Internal Revenue
    Code, section 156 of Title 35, Patents, and section 8126 of Title
    38, Veterans' Benefits, repealing sections 356 and 357 of this
    title, and enacting provisions set out as notes under sections 351
    and 355 of this title], shall take effect 90 days after the date of
    enactment of this Act [Nov. 21, 1997]."
                     EFFECTIVE DATE OF 1990 AMENDMENT
      Amendment by Pub. L. 101-535 effective six months after the date
    of the promulgation of final regulations to implement section
    343(r) of this title, or if such regulations are not promulgated,
    the date proposed regulations are to be considered as such final
    regulations (Nov. 8, 1992), with exception for persons marketing
    food the brand name of which contains a term defined by the
    Secretary under section 343(r)(2)(A)(i) of this title, see section
    10(a) of Pub. L. 101-535, set out as a note under section 343 of
    this title.
                     EFFECTIVE DATE OF 1976 AMENDMENT
      Amendment by Pub. L. 94-278 effective 180 days after Apr. 22,
    1976, see section 502(c) of Pub. L. 94-278, set out as a note under
    section 334 of this title.
                     EFFECTIVE DATE OF 1972 AMENDMENT
      Amendment by Pub. L. 92-516 effective at the close of Oct. 21,
    1972, except if regulations are necessary for the implementation of
    any provision that becomes effective on Oct. 21, 1972, and
    continuation in effect of subchapter I of chapter 6 of Title 7, and
    regulations thereunder, relating to the control of economic
    poisons, as in existence prior to Oct. 21, 1972, until superseded
    by provisions of Pub. L. 92-516, and regulations thereunder, see
    section 4 of Pub. L. 92-516, set out as an Effective Date note
    under section 136 of Title 7, Agriculture.
                     EFFECTIVE DATE OF 1970 AMENDMENT
      Amendment by Pub. L. 91-513 effective on first day of seventh
    calendar month that begins after Oct. 26, 1970, see section 704 of
    Pub. L. 91-513, set out as an Effective Date note under section 801
    of this title.
        EFFECTIVE DATE OF 1968 AMENDMENTS; TRANSITIONAL PROVISIONS
      Section 6 of Pub. L. 90-639 provided that: "The amendments made
    by this Act [amending this section, sections 331, 333, 334, and
    360a of this title, and provisions set out as a note under section
    289a of Title 42, The Public Health and Welfare] shall apply only
    with respect to violations of the Federal Food, Drug, and Cosmetic
    Act [this chapter] committed after the date of the enactment of
    this Act [Oct. 24, 1968]."
      Amendment by Pub. L. 90-399 effective on first day of thirteenth
    calendar month after July 13, 1968, except that in the case of a
    drug (other than one subject to section 360b(n) of this title)
    intended for use in animals other than man which, on Oct. 9, 1962,
    was commercially used or sold in the United States, was not a new
    drug as defined in par. (p) of this section then in force, and was
    not covered by an effective application under section 355 of this
    title, the words "effectiveness" and "effective" contained in par.
    (v) of this section not applicable to such drug when intended
    solely for use under conditions prescribed, recommended, or
    suggested in labeling with respect to such drug on that day, see
    section 108(a), (b)(3) of Pub. L. 90-399, as amended, set out as an
    Effective Date and Transitional Provisions note under section 360b
    of this title.
                     EFFECTIVE DATE OF 1965 AMENDMENT
      Section 11 of Pub. L. 89-74 provided that: "The foregoing
    provisions of this Act [see Short Title of 1965 Amendment note set
    out under section 301 of this title] shall take effect on the first
    day of the seventh calendar month [Feb. 1, 1966] following the
    month in which this Act is enacted [July 15, 1965]; except that (1)
    the Secretary shall permit persons, owning or operating any
    establishment engaged in manufacturing, preparing, propagating,
    compounding, processing, wholesaling, jobbing, or distributing any
    depressant or stimulant drug, as referred to in the amendments made
    by section 4 of this Act to section 510 of the Federal Food, Drug,
    and Cosmetic Act [section 360 of this title], to register their
    name, places of business, and establishments, and other information
    prescribed by such amendments, with the Secretary prior to such
    effective date, and (2) sections 201(v) and 511(g) of the Federal
    Food, Drug, and Cosmetic Act, as added by this act [par. (v) of
    this section and par. (g) of section 360a of this title], and the
    provisions of sections 8 [amending section 372 of this title and
    section 1114 of Title 18, Crimes and Criminal Procedure] and 10
    [set out as a note under this section] shall take effect upon the
    date of enactment of this Act [July 15, 1965]."
                     EFFECTIVE DATE OF 1962 AMENDMENT
      Section 107 of Pub. L. 87-781 provided that:
      "(a) Except as otherwise provided in this section, the amendments
    made by the foregoing sections of this part A [amending this
    section and sections 331, 332, 348, 351 to 353, 355, 357, 379e of
    this title, and enacting provisions set out as a note under section
    355 of this title] shall take effect on the date of enactment of
    this Act [Oct. 10, 1962].
      "(b) The amendments made by sections 101, 103, 105, and 106 of
    this part A [amending sections 331, 332, 351, 352, 355, and 357 of
    this title] shall, with respect to any drug, take effect on the
    first day of the seventh calendar month following the month in
    which this Act is enacted [Oct. 1962].
      "(c)(1) As used in this subsection, the term 'enactment date'
    means the date of enactment of this Act; and the term 'basic Act'
    means the Federal Food, Drug, and Cosmetic Act [this chapter].
      "(2) An application filed pursuant to section 505(b) of the basic
    Act [section 355(b) of this title] which was 'effective' within the
    meaning of that Act on the day immediately preceding the enactment
    date shall be deemed as of the enactment date, to be an application
    'approved' by the Secretary within the meaning of the basic Act as
    amended by this Act.
      "(3) In the case of any drug with respect to which an application
    filed under section 505(b) of the basic Act is deemed to be an
    approved application on the enactment date by virtue of paragraph
    (2) of this subsection -
        "(A) the amendments made by this Act to section 201(p), and to
      subsections (b) and (d) of section 505, of the basic Act [par.
      (p) of this section, and subsecs. (b) and (d) of section 355 of
      this title], insofar as such amendments relate to the
      effectiveness of drugs, shall not, so long as approval of such
      application is not withdrawn or suspended pursuant to section
      505(e) of that Act [section 355(e) of this title], apply to such
      drug when intended solely for use under conditions prescribed,
      recommended, or suggested in labeling covered by such approved
      application, but shall apply to any changed use, or conditions of
      use, prescribed, recommended, or suggested in its labeling,
      including such conditions of use as are the subject of an
      amendment or supplement to such application pending on, or filed
      after, the enactment date; and
        "(B) clause (3) of the first sentence of section 505(e) of the
      basic Act, as amended by this Act [section 355(e) of this title],
      shall not apply to such drug when intended solely for use under
      conditions prescribed, recommended, or suggested in labeling
      covered by such approved application (except with respect to such
      use, or conditions of use, as are the subject of an amendment or
      supplement to such approved application, which amendment or
      supplement has been approved after the enactment date under
      section 505 of the basic Act as amended by this Act [section 355
      of this title]) until whichever of the following first occurs:
      (i) the expiration of the two-year period beginning with the
      enactment date; (ii) the effective date of an order under section
      505(e) of the basic Act [section 355(e) of this title], other
      than clause (3) of the first sentence of such section 505(e)
      [section 355(e) of this title], withdrawing or suspending the
      approval of such application.
      "(4) In the case of any drug which, on the day immediately
    preceding the enactment date, (A) was commercially used or sold in
    the United States, (B) was not a new drug as defined by section
    201(p) of the basic Act as then in force [par. (p) of this
    section], and (C) was not covered by an effective application under
    section 505 of that Act [section 355 of this title], the amendments
    to section 201(p) [par. (p) of this section] made by this Act shall
    not apply to such drug when intended solely for use under
    conditions prescribed, recommended, or suggested in labeling with
    respect to such drug on that day."
                     EFFECTIVE DATE OF 1960 AMENDMENT
      Amendment by Pub. L. 86-618 effective July 12, 1960, subject to
    provisions of section 203 of Pub. L. 86-618, see section 202 of
    Pub. L. 86-618, set out as a note under section 379e of this title.
                     EFFECTIVE DATE OF 1958 AMENDMENT
      Amendment by Pub. L. 85-929 effective Sept. 6, 1958, see section
    6(a) of Pub. L. 85-929, set out as a note under section 342 of this
    title.
                     EFFECTIVE DATE OF 1954 AMENDMENT
      For effective date of amendment by act July 22, 1954, see section
    5 of that act, set out as a note under section 342 of this title.
               CONSTRUCTION OF AMENDMENTS BY PUB. L. 102-282
      Amendment by Pub. L. 102-282 not to preclude any other civil,
    criminal, or administrative remedy provided under Federal or State
    law, including any private right of action against any person for
    the same action subject to any action or civil penalty under an
    amendment made by Pub. L. 102-282, see section 7 of Pub. L. 102-
    282, set out as a note under section 335a of this title.
               CONSTRUCTION OF AMENDMENTS BY PUB. L. 101-535
      Amendments by Pub. L. 101-535 not to be construed to alter
    authority of Secretary of Health and Human Services and Secretary
    of Agriculture under the Federal Food, Drug, and Cosmetic Act (21
    U.S.C. 301 et seq.), the Federal Meat Inspection Act (21 U.S.C. 601
    et seq.), the Poultry Products Inspection Act (21 U.S.C. 451 et
    seq.), and the Egg Products Inspection Act (21 U.S.C. 1031 et
    seq.), see section 9 of Pub. L. 101-535, set out as a note under
    section 343 of this title.
                             SAVINGS PROVISION
      Section 702 of Pub. L. 91-513, as amended by Pub. L. 93-481, Sec.
    2, Oct. 26, 1974, 88 Stat. 1455, provided that:
      "(a) Prosecutions for any violation of law occurring prior to the
    effective date [see Effective Date of 1970 Amendment note above] of
    section 701 [repealing section 360a of this title, and amending
    sections 321, 331, 333, 334, 360, 372, and 381 of this title,
    sections 1114 and 1952 of Title 18, Crimes and Criminal Procedure,
    and section 242 of Title 42, The Public Health and Welfare] shall
    not be affected by the repeals or amendments made by such section,
    or abated by reason thereof.
      "(b) Civil seizures or forfeitures and injunctive proceedings
    commenced prior to the effective date of section 701 shall not be
    affected by the repeals or amendments made by such section, or
    abated by reason thereof.
      "(c) All administrative proceedings pending before the Bureau of
    Narcotics and Dangerous Drugs [now the Drug Enforcement
    Administration] on the date of enactment of this Act [Oct. 27,
    1970] shall be continued and brought to final determination in
    accord with laws and regulations in effect prior to such date of
    enactment. Where a drug is finally determined under such
    proceedings to be a depressant or stimulant drug, as defined in
    section 201(v) of the Federal Food, Drug, and Cosmetic Act [par.
    (v) of this section], such drug shall automatically be controlled
    under this title [subchapter I of chapter 13 of this title] by the
    Attorney General without further proceedings and listed in the
    appropriate schedule after he has obtained the recommendation of
    the Secretary. Any drug with respect to which such a final
    determination has been made prior to the date of enactment of this
    Act which is not listed in section 202 [section 812 of this title]
    within schedules I through V shall automatically be controlled
    under this title [subchapter I of chapter 13 of this title] by the
    Attorney General without further proceedings, and be listed in the
    appropriate schedule, after he has obtained the recommendations of
    the Secretary.
      "(d) Notwithstanding subsection (a) of this section or section
    1103 [of Pub. L. 91-513, set out as a note under sections 171 to
    174 of this title], section 4202 of title 18, United States Code,
    shall apply to any individual convicted under any of the laws
    repealed by this title or title III [subchapter I or subchapter II
    of chapter 13 of this title] without regard to the terms of any
    sentence imposed on such individual under such law."

TRANSFER OF FUNCTIONS

      Secretary and Department of Health, Education, and Welfare
    redesignated Secretary and Department of Health and Human Services
    by Pub. L. 96-88, title V, Sec. 509(b), Oct. 17, 1979, 93 Stat.
    695, which is classified to section 3508(b) of Title 20, Education.
      Functions of Secretary of Health, Education, and Welfare [now
    Health and Human Services] under Federal Food, Drug, and Cosmetic
    Act, to the extent such functions related to administration and
    enforcement of the Poison Prevention Packaging Act of 1970 (15
    U.S.C. 1471 et seq.), transferred to Consumer Product Safety
    Commission by section 2079 of Title 15, Commerce and Trade.
      Functions of Secretary of Health, Education, and Welfare [now
    Health and Human Services] under Drug Abuse Control Amendments of
    1965 [see Short Title of 1965 Amendment note set out under section
    301 of this title] transferred to Attorney General except function
    of regulating counterfeiting of those drugs which are not
    "depressant or stimulant" drugs, see section 2 of Reorg. Plan No. 1
    of 1968, set out in the Appendix to Title 5, Government
    Organization and Employees.
      Functions of Federal Security Administrator transferred to
    Secretary of Health, Education, and Welfare and all agencies of
    Federal Security Agency transferred to Department of Health,
    Education, and Welfare by section 5 of Reorg. Plan No. 1 of 1953,
    set out in the Appendix to Title 5, Government Organization and
    Employees. Federal Security Agency and office of Administrator
    abolished by section 8 of Reorg. Plan No. 1 of 1953.
      Food and Drug Administration in Department of Agriculture and its
    functions, except those functions relating to administration of
    Insecticide Act of 1910 and Naval Stores Act, transferred to
    Federal Security Agency, to be administered under direction and
    supervision of Federal Security Administrator, by Reorg. Plan No.
    IV of 1940, set out in the Appendix to Title 5.

REGULATION OF TOBACCO

      Section 422 of Pub. L. 105-115 provided that: "Nothing in this
    Act [see Short Title of 1997 Amendment note set out under section
    301 of this title] or the amendments made by this Act shall be
    construed to affect the question of whether the Secretary of Health
    and Human Services has any authority to regulate any tobacco
    product, tobacco ingredient, or tobacco additive. Such authority,
    if any, shall be exercised under the Federal Food, Drug, and
    Cosmetic Act [21 U.S.C. 301 et seq.] as in effect on the day before
    the date of the enactment of this Act [Nov. 21, 1997]."
            CONGRESSIONAL FINDINGS RELATING TO PUB. L. 103-417
      Section 2 of Pub. L. 103-417 provided that: "Congress finds that -
        "(1) improving the health status of United States citizens
      ranks at the top of the national priorities of the Federal
      Government;
        "(2) the importance of nutrition and the benefits of dietary
      supplements to health promotion and disease prevention have been
      documented increasingly in scientific studies;
        "(3)(A) there is a link between the ingestion of certain
      nutrients or dietary supplements and the prevention of chronic
      diseases such as cancer, heart disease, and osteoporosis; and
        "(B) clinical research has shown that several chronic diseases
      can be prevented simply with a healthful diet, such as a diet
      that is low in fat, saturated fat, cholesterol, and sodium, with
      a high proportion of plant-based foods;
        "(4) healthful diets may mitigate the need for expensive
      medical procedures, such as coronary bypass surgery or
      angioplasty;
        "(5) preventive health measures, including education, good
      nutrition, and appropriate use of safe nutritional supplements
      will limit the incidence of chronic diseases, and reduce long-
      term health care expenditures;
        "(6)(A) promotion of good health and healthy lifestyles
      improves and extends lives while reducing health care
      expenditures; and
        "(B) reduction in health care expenditures is of paramount
      importance to the future of the country and the economic well-
      being of the country;
        "(7) there is a growing need for emphasis on the dissemination
      of information linking nutrition and long-term good health;
        "(8) consumers should be empowered to make choices about
      preventive health care programs based on data from scientific
      studies of health benefits related to particular dietary
      supplements;
        "(9) national surveys have revealed that almost 50 percent of
      the 260,000,000 Americans regularly consume dietary supplements
      of vitamins, minerals, or herbs as a means of improving their
      nutrition;
        "(10) studies indicate that consumers are placing increased
      reliance on the use of nontraditional health care providers to
      avoid the excessive costs of traditional medical services and to
      obtain more holistic consideration of their needs;
        "(11) the United States will spend over $1,000,000,000,000 on
      health care in 1994, which is about 12 percent of the Gross
      National Product of the United States, and this amount and
      percentage will continue to increase unless significant efforts
      are undertaken to reverse the increase;
        "(12)(A) the nutritional supplement industry is an integral
      part of the economy of the United States;
        "(B) the industry consistently projects a positive trade
      balance; and
        "(C) the estimated 600 dietary supplement manufacturers in the
      United States produce approximately 4,000 products, with total
      annual sales of such products alone reaching at least
      $4,000,000,000;
        "(13) although the Federal Government should take swift action
      against products that are unsafe or adulterated, the Federal
      Government should not take any actions to impose unreasonable
      regulatory barriers limiting or slowing the flow of safe products
      and accurate information to consumers;
        "(14) dietary supplements are safe within a broad range of
      intake, and safety problems with the supplements are relatively
      rare; and
        "(15)(A) legislative action that protects the right of access
      of consumers to safe dietary supplements is necessary in order to
      promote wellness; and
        "(B) a rational Federal framework must be established to
      supersede the current ad hoc, patchwork regulatory policy on
      dietary supplements."
     DISSEMINATION OF INFORMATION REGARDING THE DANGERS OF DRUG ABUSE
      Section 5 of Pub. L. 90-639 provided that: "It is the sense of
    the Congress that, because of the inadequate knowledge on the part
    of the people of the United States of the substantial adverse
    effects of misuse of depressant and stimulant drugs, and of other
    drugs liable to abuse, on the individual, his family, and the
    community, the highest priority should be given to Federal programs
    to disseminate information which may be used to educate the public,
    particularly young persons, regarding the dangers of drug abuse."
             CONGRESSIONAL FINDINGS AND DECLARATION OF POLICY
      Section 2 of Pub. L. 89-74 provided that: "The Congress hereby
    finds and declares that there is a widespread illicit traffic in
    depressant and stimulant drugs moving in or otherwise affecting
    interstate commerce; that the use of such drugs, when not under the
    supervision of a licensed practitioner, often endangers safety on
    the highways (without distinction of interstate and intrastate
    traffic thereon) and otherwise has become a threat to the public
    health and safety, making additional regulation of such drugs
    necessary regardless of the intrastate or interstate origin of such
    drugs; that in order to make regulation and protection of
    interstate commerce in such drugs effective, regulation of
    intrastate commerce is also necessary because, among other things,
    such drugs, when held for illicit sale, often do not bear labeling
    showing their place of origin and because in the form in which they
    are so held or in which they are consumed a determination of their
    place of origin is often extremely difficult or impossible; and
    that regulation of interstate commerce without the regulation of
    intrastate commerce in such drugs, as provided in this Act [see
    Short Title of 1965 Amendment note set out under section 301 of
    this title], would discriminate against and adversely affect
    interstate commerce in such drugs."
       EFFECT OF DRUG ABUSE CONTROL AMENDMENTS OF 1965 ON STATE LAWS
      Section 10 of Pub. L. 89-74 provided that:
      "(a) Nothing in this Act [enacting section 360a of this title,
    amending sections 321, 331, 333, 334, 360, and 372 of this title
    and section 1114 of Title 18, Crimes and Criminal Procedure, and
    enacting provisions set out as notes under sections 321, 352, and
    360a of this title] shall be construed as authorizing the
    manufacture, compounding, processing, possession, sale, delivery,
    or other disposal of any drug in any State in contravention of the
    laws of such State.
      "(b) No provision of this Act nor any amendment made by it shall
    be construed as indicating an intent on the part of the Congress to
    occupy the field in which such provision or amendment operates to
    the exclusion of any State law on the same subject matter, unless
    there is a direct and positive conflict between such provision or
    amendment and such State law so that the two cannot be reconciled
    or consistently stand together.
      "(c) No amendment made by this Act shall be construed to prevent
    the enforcement in the courts of any State of any statute of such
    State prescribing any criminal penalty for any act made criminal by
    any such amendment."
              EFFECT OF DRUG AMENDMENTS OF 1962 ON STATE LAWS
      Section 202 of Pub. L. 87-781 provided that: "Nothing in the
    amendments made by this Act [enacting sections 358 to 360, amending
    sections 321, 331, 332, 348, 351 to 353, 355, 357, 372, 374, 379e,
    and 381 of this title, and enacting provisions set out as notes
    under sections 321, 331, 332, 352, 355, 360, and 374 of this title]
    to the Federal Food, Drug, and Cosmetic Act [this chapter] shall be
    construed as invalidating any provision of State law which would be
    valid in the absence of such amendments unless there is a direct
    and positive conflict between such amendments and such provision of
    State law."

DEFINITIONS

      Section 2 of Pub. L. 105-115 provided that: "In this Act [see
    Short Title of 1997 Amendment note set out under section 301 of
    this title], the terms 'drug', 'device', 'food', and 'dietary
    supplement' have the meaning given such terms in section 201 of the
    Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)."

FOOTNOTE

    (!1) So in original. Probably should be paragraph "(v)".
Customized queries of TRAC's data TRAC FBI Web Site TRAC DEA Web Site TRAC Immigration Web Site TRAC DHS Web Site TRAC IRS Web Site TRAC ATF Web Site TRAC Reports Web Site
Transactional Records Access Clearinghouse, Syracuse University
Copyright 2010
TRAC Web Site